PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463086
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463086
The global laser capture microdissection market size is expected to reach USD 397.74 million by 2032, according to a new study by Polaris Market Research. The report "Laser Capture Microdissection Market Share, Size, Trends, Industry Analysis Report, By Product (Consumables, Instruments, Software And Services); By System Type; By Application; By End-Use; By Region.; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Laser capture microdissection (LCM) revolutionizes the process of isolating specific single cells or entire tissue areas from diverse samples, all while maintaining a contact- and contamination-free environment under direct microscopic visualization. This advanced technique plays a crucial role in preserving the original morphology of dissected tissue samples by meticulously isolating desired cells and excluding unwanted ones. By harvesting cells of interest directly, LCM ensures the extraction of pure, enriched cells while preserving the authentic morphology of the dissected sample.
The rise in research and development funding and increased healthcare expenditure propels market growth, underscoring the growing importance of innovative technologies in biomedical research and diagnostics. Furthermore, the adoption of microdissection techniques for isolating morphologically recognized cell populations from tissue sections and cytological preparations addresses the challenge of tissue complexity, driving market expansion.
Moreover, the rising popularity of laser capture microdissection stems from its ability to enable accurate, in vivo investigation of cell populations, such as malignant cells associated with Hodgkin's disease or carcinoma in situ. This precision, coupled with sensitive analytical techniques like the polymerase chain reaction, provides insights previously inaccessible through conventional molecular studies, thereby positively influencing market dynamics.
Additionally, factors such as the establishment of "genetic fingerprints" for specific pathological lesions, advancements in technology, and the utilization of contamination-free techniques contribute to market growth. The continuous growth in population and improvements in healthcare infrastructure further bolster the demand for laser-capture microdissection technologies, highlighting their significance in advancing biomedical research and clinical diagnostics.
In 2023, the ultraviolet LCM segment accounted for the largest market share, due to economies of scale, technological advancements, and heightened competition among manufacturers, UV laser capture microdissection (LCM) systems have experienced a notable decrease in cost and increased accessibility over time.
The diagnostics segment is expected to grow at the fastest CAGR during the forecast period. As cancer diagnostics and biomarker discovery efforts intensify, the demand for LCM technologies is projected to grow rapidly within the diagnostics segment.
In 2023, North America dominated the largest market share, as it is home to major manufacturers and suppliers of LCM instruments, accessories, and consumables, driving the availability and adoption of state-of-the-art technologies in the market.
Asia Pacific is expected to grow at the fastest CAGR in laser processing market. The Asia-Pacific region is experiencing a rise in the prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes. This trend is attributed to factors such as aging populations, urbanization, and lifestyle changes.
The global key market players are Agilent Technologies Inc., AnaPath Services GmbH, CaresBio Laboratory LLC, Danaher Life Sciences, LLC., Episteme LTD., Laxco Inc., Roche Molecular Systems, Inc., and more.
Polaris Market Research has segmented the laser capture microdissection market report based on product, system type, application, end-use and region.